The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway

BACKGROUND: Neo-adjuvant breast cancer clinical trials of zoledronic acid (ZOL) have shown that patients with oestrogen negative (ER-ve) tumours have improved disease outcomes. We investigated the molecular mechanism behind this differential anti-tumour effect according to ER status, hypothesising i...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:BMC Cancer
Main Authors: Wilson, Caroline, Ottewell, Penelope, Coleman, Robert E, Holen, Ingunn
Formáid: Artigo
Teanga:Inglês
Foilsithe: BioMed Central 2015
Ábhair:
Research Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329195/
https://ncbi.nlm.nih.gov/pubmed/25884855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1066-7
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla